Tags

Type your tag names separated by a space and hit enter

Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon.

Abstract

BACKGROUND

A new intragastric balloon is available for weight reduction.

METHODS

Patients consulting for a weight reduction plan and refusing any kind of actual surgery, or suffering from obesity but not meeting the IFSO standards for surgery, were offered the possibility of weight reduction by the BioEnterics intragastric balloon (BIB). A preoperative questionnaire was completed by all patients, inquiring about medical history, co-morbidity factors, dietary habits, previous treatments for weight and social, psychological, relational and economic impact of the obesity. BIB placement was done on an inpatient basis, under general anesthesia. Inflation was standardized at 500 ml saline. Intravenous antiemetic and spasmolytic drugs were given to control post-insertion nausea for 24 hours, and oral medication was administered on the patient's discharge. A standard 800 calorie diet was prescribed after dietitian's consultation. Extraction of the balloon was left to the patient's discretion at 3 or maximum 6 months after placement. Patients choosing for the maximal period received a formal invitation to extract the balloon. Evaluation of weight reduction was done at extraction and by questionnaire.

RESULTS

126 patients (5 M, 121 F) with mean age of 35.6 years (20-62) were included after preoperative evaluation. Mean preoperative BMI was 37.7 kg/m2 (26.7-57.7 kg/m2), with a mean initial excessive weight of 35.3 kg (8.8-96.4 kg) and mean initial % excess weight of 32.2 (6.3-102). 69 patients were eligible for review; mean excess weight loss after 3 months was 48.6% and after 6 months 50.8%. Mean weight loss was 15.4 kg (0-35 kg). 76.8% of the patients (41/69) complained of severe nausea and vomiting lasting an average of 1 week (1 day-6 months), resulting in 3 patients in early removal of the balloon (at 1 day, 1 week, 1 month after placement respectively). 2 patients suffered gastric perforation presenting as acute peritonitis 3 and 4 months after placement and were operated. Extraction of the balloon was performed in 3 patients after 3 months and in 66 patients after 6 months. In 11 patients (22%), esophagitis was present (8 grade 1, 2 grade II, 1 grade III), and one patient showed diffuse gastric erosion. One patient required removal of the balloon by rigid esphagoscopy following technical failure of the endoscopic extraction device. 45 patients replied to the mailed, questionnaire; 15% (7/45) were very satisfied, 13% (6/45) satisfied, 22% (10/45) reasonably satisfied, 8.8% (4/45) unsatisfied and 40% very unsatisfied. Degree of satisfaction correlated poorly with weight loss. Results may be better with close continuous guidance by a counselor.

CONCLUSION

BIB as a means of weight reduction in the obese patient led to a 50.8% loss of excess weight after 6 months. Although severe morbidity can occur, the BIB provides a means for short-term weight reduction in conjunction with dietary measures.

Links

  • Aggregator Full Text
  • Authors+Show Affiliations

    ,

    Academic Surgical Center Stuivenberg, Lange Beeldenkenstraat 267, B-2060 Antwerp, Belgium. totte@village.uunet.be

    , ,

    Source

    Obesity surgery 11:4 2001 Aug pg 519-23

    MeSH

    Adult
    Body Mass Index
    Catheterization
    Combined Modality Therapy
    Diet, Reducing
    Follow-Up Studies
    Gastric Balloon
    Humans
    Middle Aged
    Nausea
    Obesity, Morbid
    Patient Satisfaction
    Patient Selection
    Peritonitis
    Quality of Life
    Satiation
    Stomach
    Surveys and Questionnaires
    Time Factors
    Treatment Outcome
    Vomiting
    Weight Loss

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    11501367

    Citation

    Totté, E, et al. "Weight Reduction By Means of Intragastric Device: Experience With the Bioenterics Intragastric Balloon." Obesity Surgery, vol. 11, no. 4, 2001, pp. 519-23.
    Totté E, Hendrickx L, Pauwels M, et al. Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. Obes Surg. 2001;11(4):519-23.
    Totté, E., Hendrickx, L., Pauwels, M., & Van Hee, R. (2001). Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. Obesity Surgery, 11(4), pp. 519-23.
    Totté E, et al. Weight Reduction By Means of Intragastric Device: Experience With the Bioenterics Intragastric Balloon. Obes Surg. 2001;11(4):519-23. PubMed PMID: 11501367.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. AU - Totté,E, AU - Hendrickx,L, AU - Pauwels,M, AU - Van Hee,R, PY - 2001/8/15/pubmed PY - 2002/1/5/medline PY - 2001/8/15/entrez SP - 519 EP - 23 JF - Obesity surgery JO - Obes Surg VL - 11 IS - 4 N2 - BACKGROUND: A new intragastric balloon is available for weight reduction. METHODS: Patients consulting for a weight reduction plan and refusing any kind of actual surgery, or suffering from obesity but not meeting the IFSO standards for surgery, were offered the possibility of weight reduction by the BioEnterics intragastric balloon (BIB). A preoperative questionnaire was completed by all patients, inquiring about medical history, co-morbidity factors, dietary habits, previous treatments for weight and social, psychological, relational and economic impact of the obesity. BIB placement was done on an inpatient basis, under general anesthesia. Inflation was standardized at 500 ml saline. Intravenous antiemetic and spasmolytic drugs were given to control post-insertion nausea for 24 hours, and oral medication was administered on the patient's discharge. A standard 800 calorie diet was prescribed after dietitian's consultation. Extraction of the balloon was left to the patient's discretion at 3 or maximum 6 months after placement. Patients choosing for the maximal period received a formal invitation to extract the balloon. Evaluation of weight reduction was done at extraction and by questionnaire. RESULTS: 126 patients (5 M, 121 F) with mean age of 35.6 years (20-62) were included after preoperative evaluation. Mean preoperative BMI was 37.7 kg/m2 (26.7-57.7 kg/m2), with a mean initial excessive weight of 35.3 kg (8.8-96.4 kg) and mean initial % excess weight of 32.2 (6.3-102). 69 patients were eligible for review; mean excess weight loss after 3 months was 48.6% and after 6 months 50.8%. Mean weight loss was 15.4 kg (0-35 kg). 76.8% of the patients (41/69) complained of severe nausea and vomiting lasting an average of 1 week (1 day-6 months), resulting in 3 patients in early removal of the balloon (at 1 day, 1 week, 1 month after placement respectively). 2 patients suffered gastric perforation presenting as acute peritonitis 3 and 4 months after placement and were operated. Extraction of the balloon was performed in 3 patients after 3 months and in 66 patients after 6 months. In 11 patients (22%), esophagitis was present (8 grade 1, 2 grade II, 1 grade III), and one patient showed diffuse gastric erosion. One patient required removal of the balloon by rigid esphagoscopy following technical failure of the endoscopic extraction device. 45 patients replied to the mailed, questionnaire; 15% (7/45) were very satisfied, 13% (6/45) satisfied, 22% (10/45) reasonably satisfied, 8.8% (4/45) unsatisfied and 40% very unsatisfied. Degree of satisfaction correlated poorly with weight loss. Results may be better with close continuous guidance by a counselor. CONCLUSION: BIB as a means of weight reduction in the obese patient led to a 50.8% loss of excess weight after 6 months. Although severe morbidity can occur, the BIB provides a means for short-term weight reduction in conjunction with dietary measures. SN - 0960-8923 UR - https://www.unboundmedicine.com/medline/citation/11501367/Weight_reduction_by_means_of_intragastric_device:_experience_with_the_bioenterics_intragastric_balloon_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=11501367.ui DB - PRIME DP - Unbound Medicine ER -